PT946525E - Processo para a preparacao de complexos metalicos de carbonamidas - Google Patents

Processo para a preparacao de complexos metalicos de carbonamidas

Info

Publication number
PT946525E
PT946525E PT97951981T PT97951981T PT946525E PT 946525 E PT946525 E PT 946525E PT 97951981 T PT97951981 T PT 97951981T PT 97951981 T PT97951981 T PT 97951981T PT 946525 E PT946525 E PT 946525E
Authority
PT
Portugal
Prior art keywords
carboxylic acid
metal complex
carbonamides
preparation
complex carboxylic
Prior art date
Application number
PT97951981T
Other languages
English (en)
Inventor
Bernd Raduchel
Johannes Platzek
Heribert Schmitt-Willich
Klaus-Dieter Graske
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT946525E publication Critical patent/PT946525E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/143—Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT97951981T 1996-12-04 1997-11-26 Processo para a preparacao de complexos metalicos de carbonamidas PT946525E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652386A DE19652386A1 (de) 1996-12-04 1996-12-04 Verfahren zur Herstellung von Metallkomplexcarbonsäureamiden

Publications (1)

Publication Number Publication Date
PT946525E true PT946525E (pt) 2004-08-31

Family

ID=7814928

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97951981T PT946525E (pt) 1996-12-04 1997-11-26 Processo para a preparacao de complexos metalicos de carbonamidas

Country Status (12)

Country Link
EP (1) EP0946525B1 (pt)
JP (1) JP4278182B2 (pt)
AT (1) ATE263758T1 (pt)
AU (1) AU5556698A (pt)
DE (2) DE19652386A1 (pt)
DK (1) DK0946525T3 (pt)
ES (1) ES2218711T3 (pt)
NO (1) NO312724B1 (pt)
PT (1) PT946525E (pt)
TW (1) TW438804B (pt)
WO (1) WO1998024775A1 (pt)
ZA (1) ZA9710930B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19905094C1 (de) * 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel
DE10105014C2 (de) * 2001-01-26 2003-03-27 Schering Ag Neues Verfahren zur Herstellung von Monoamiden der DTPA
FR2856063B1 (fr) * 2003-06-13 2005-10-07 Air Liquide Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
DE102007002726A1 (de) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101334780B1 (ko) 2010-08-13 2013-12-02 한국생명공학연구원 요오드를 함유한 방사형상의 고분자 화합물, 이의 제조방법 및 이를 포함하는 ｃｔ용 조영제 조성물
CA2900595A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
EP3101012A1 (en) * 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10975060B2 (en) 2016-11-28 2021-04-13 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
PE20211471A1 (es) 2018-11-23 2021-08-05 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos
CN111004623B (zh) * 2019-12-20 2023-07-18 河北科技大学 一种卟啉类荧光材料及其制备方法
EP4360660A1 (en) 2022-10-24 2024-05-01 Bayer AG Process for the preparation of a gadolinium contrast agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe

Also Published As

Publication number Publication date
WO1998024775A1 (de) 1998-06-11
JP4278182B2 (ja) 2009-06-10
ATE263758T1 (de) 2004-04-15
EP0946525A1 (de) 1999-10-06
ES2218711T3 (es) 2004-11-16
NO992710L (no) 1999-06-03
NO312724B1 (no) 2002-06-24
DE19652386A1 (de) 1998-06-10
DK0946525T3 (da) 2004-08-02
JP2001504844A (ja) 2001-04-10
AU5556698A (en) 1998-06-29
NO992710D0 (no) 1999-06-03
DE59711504D1 (de) 2004-05-13
TW438804B (en) 2001-06-07
ZA9710930B (en) 1998-09-08
EP0946525B1 (de) 2004-04-07

Similar Documents

Publication Publication Date Title
PT946525E (pt) Processo para a preparacao de complexos metalicos de carbonamidas
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
PT98205A (pt) Processo para a preparacao de novos derivados beta-lactamicos
PT95496A (pt) Processo para a nitrocarburacao de componentes de aco
BR9811235A (pt) Processo para a produção de uma amina aromática
FI933546A0 (fi) Kemisk process
HUP0104714A2 (hu) Eljárás szerves folyadékok víztelenítésére
ES2054755T3 (es) Un proceso para la produccion de 2,4,5-trifluoroisoftalonitrilo.
IL114488A0 (en) Amino acid-derived diaminopropanols
BR9406352A (pt) Processo para a fabricição de ácido aminometanofosfonico
IT1210910B (it) Miglioramento del procedimento per preparare composti biarilici via copulazione di un'arilammina con un arene.
PT1019347E (pt) Metodo para a sintese de taxanos
IL131513A0 (en) Method for producing 1,3-di-substituted 2-nitroguanidines
BR9405186A (pt) Processo para a preparação de 2,4,5-tribromopirrol-3-carbonitrila
PT1104397E (pt) Processo para a preparacao de ester de etilo do acido atropico
IL105657A (en) Process for the preparation of 5-chloroxindole
ATE366255T1 (de) Verfahren zur herstellung halogenierter beta- lactamverbindungen
KR910000733A (ko) 피롤리진 유도체 제조방법
RU93011399A (ru) Способ получения водосвязующего дисперсных алюмосиликатных систем
ATE240933T1 (de) Verfahren zum herstellen von alpha- arylalkansäuren
WO1996016077A3 (en) Reagent for quantifying free amine groups
MX9601073A (es) Reactivo y procedimiento para la sintesis de derivados organicos oxisulfurados y fluorados.
CA2042019A1 (en) Process for producing n-(3', 4'-dimethoxycinnamoyl)-anthranilic acid
SU1767839A1 (ru) Способ получения адамантан-1-карбоновой кислоты
UA10291C2 (uk) Спосіб одержання в'яжучого для шляхового будівництва